B. Newstat

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

David Cameron, Michelle Casey, Michael F. Press et al. · Breast Cancer Research and Treatment · 2008 · 803 citations

Medicine, Oncology, Pharmacology +17

Lapatinib Plus Capecitabine in Women with HER-2–Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized Trial

David Cameron, Michelle Casey, Cristina Oliva et al. · The Oncologist · 2010 · 308 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized Trial of Lapatinib Versus Placebo Added to Paclitaxel in the Treatment of Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer

Zhongzhen Guan, Binghe Xu, Michelle DeSilvio et al. · Journal of Clinical Oncology · 2013 · 139 citations

Medicine, Oncology, Pharmacology +17

Pooled analysis of diarrhea events in patients with cancer treated with lapatinib

John Crown, H. A. Burris, Frances M. Boyle et al. · Breast Cancer Research and Treatment · 2008 · 98 citations

Medicine, Oncology, Pharmacology +10

Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients

Bing-He Xu, Ze-Fei Jiang, Daniel T. T. Chua et al. · Chinese Journal of Cancer · 2011 · 45 citations · Full text

Medicine, Oncology, Pharmacology +16